• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临时配制的无醇苯巴比妥混悬液的稳定性

Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.

作者信息

Cober Mary Petrea, Johnson Cary E

机构信息

Department of Pharmacy, University of Michigan Hospitals and Health Centers (UMHHC), College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Am J Health Syst Pharm. 2007 Mar 15;64(6):644-6. doi: 10.2146/ajhp060107.

DOI:10.2146/ajhp060107
PMID:17353574
Abstract

PURPOSE

The physical and chemical short-term stability of alcohol-free, oral suspensions of phenobarbital 10 mg/mL prepared from commercially available tablets in both a sugar and a sugar-free vehicle was assessed at room temperature.

METHODS

Phenobarbital oral suspension 10 mg/mL was prepared by crushing 10 60-mg tablets of phenobarbital with a mortar and pestle. A small amount of Ora-Plus was added to the phenobarbital powder to sufficiently wet the particles. A 1:1 mixture of Ora-Plus and either Ora-Sweet or Ora-Sweet SF was combined with the phenobarbital powder to produce a final volume of 60 mL. Three identical samples of each of the two different formulations were prepared and stored at room temperature in 2-oz amber plastic bottles. Immediately after preparation and at 15, 30, 60, and 115 days, the samples were assayed in duplicate by stability-indicating high-performance liquid chromatography. The samples were tasted and inspected for color and odor changes. The percent of the initial concentration remaining at each study time for each phenobarbital suspension was determined. Stability was defined as the retention of at least 90% of the initial concentration.

RESULTS

There were no detectable changes in color, odor, and taste and no visible microbial growth in any sample. At least 98% of the initial phenobarbital concentration remained throughout the 115-day study period in both preparations.

CONCLUSION

An extemporaneously prepared alcohol-free suspension of phenobarbital 10 mg/mL in a 1:1 mixture of Ora-Plus and Ora-Sweet or Ora-Sweet SF was stable for at least 115 days when stored in 2-oz amber plastic bottles at room temperature.

摘要

目的

评估由市售片剂制备的10mg/mL苯巴比妥无糖和含糖口服混悬液在室温下的物理和化学短期稳定性。

方法

用研钵和研杵将10片60mg的苯巴比妥片剂碾碎,制备10mg/mL苯巴比妥口服混悬液。向苯巴比妥粉末中加入少量Ora-Plus以充分湿润颗粒。将Ora-Plus与Ora-Sweet或Ora-Sweet SF按1:1混合后与苯巴比妥粉末混合,最终体积为60mL。制备两种不同制剂的三个相同样品,并在室温下储存在2盎司琥珀色塑料瓶中。制备后立即以及在第15、30、60和115天,通过稳定性指示高效液相色谱法对样品进行一式两份测定。品尝样品并检查颜色和气味变化。测定每种苯巴比妥混悬液在每个研究时间剩余的初始浓度百分比。稳定性定义为保留至少90%的初始浓度。

结果

任何样品均未检测到颜色、气味和味道变化,也没有可见的微生物生长。在整个115天的研究期间,两种制剂中苯巴比妥的初始浓度至少保留了98%。

结论

当在室温下储存在2盎司琥珀色塑料瓶中时,由Ora-Plus与Ora-Sweet或Ora-Sweet SF按1:1混合临时制备的10mg/mL苯巴比妥无糖混悬液至少稳定115天。

相似文献

1
Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.临时配制的无醇苯巴比妥混悬液的稳定性
Am J Health Syst Pharm. 2007 Mar 15;64(6):644-6. doi: 10.2146/ajhp060107.
2
Stability of an extemporaneous alcohol-free melatonin suspension.无醇褪黑素混悬液的稳定性。
Am J Health Syst Pharm. 2011 Mar 1;68(5):420-3. doi: 10.2146/ajhp100274.
3
Stability of extemporaneously prepared moxifloxacin oral suspensions.莫西沙星口服混悬液的临时配制稳定性。
Am J Health Syst Pharm. 2009 Apr 1;66(7):665-7. doi: 10.2146/ajhp080152.
4
Stability of extemporaneously prepared glycopyrrolate oral suspensions.临时制备的格隆溴铵口服混悬液的稳定性。
Am J Health Syst Pharm. 2011 May 1;68(9):843-5. doi: 10.2146/100247.
5
Stability of extemporaneously prepared rifaximin oral suspensions.利福昔明口服混悬剂的稳定性。
Am J Health Syst Pharm. 2010 Feb 15;67(4):287-9. doi: 10.2146/ajhp090206.
6
Stability of extemporaneously prepared rufinamide oral suspensions.临时制备的雷夫酰胺口服混悬液的稳定性。
Ann Pharmacother. 2010 Mar;44(3):462-5. doi: 10.1345/aph.1M647. Epub 2010 Feb 11.
7
Stability of extemporaneously prepared oxandrolone oral suspensions.昂丹司琼口服液的稳定性。
Am J Health Syst Pharm. 2011 Mar 15;68(6):519-21. doi: 10.2146/ajhp100225.
8
Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.临时配制的苯丁酸钠口服混悬液的稳定性。
Am J Health Syst Pharm. 2007 Jul 15;64(14):1513-5. doi: 10.2146/ajhp060450.
9
Stability of extemporaneously prepared cinacalcet oral suspensions.西那卡塞临时配制口服混悬液的稳定性
Am J Health Syst Pharm. 2018 May 1;75(9):e236-e240. doi: 10.2146/ajhp170072.
10
Stability of an extemporaneously prepared thalidomide suspension.临用前配制的沙利度胺混悬液的稳定性。
Am J Health Syst Pharm. 2012 Jan 1;69(1):56-8. doi: 10.2146/ajhp110105.

引用本文的文献

1
Ethanol Content of Medications and Its Effect on Blood Alcohol Concentration in Pediatric Patients.药物中的乙醇含量及其对儿科患者血液酒精浓度的影响。
J Pediatr Pharmacol Ther. 2024 Apr;29(2):188-194. doi: 10.5863/1551-6776-29.2.188. Epub 2024 Apr 8.
2
The Past, Present, and Future of Oral Dosage Forms for Children.儿童口服剂型的过去、现在与未来
J Pediatr Pharmacol Ther. 2024;29(1):22-31. doi: 10.5863/1551-6776-29.1.22. Epub 2024 Feb 7.
3
Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome.
苯巴比妥和可乐定作为新生儿阿片类药物戒断综合征的二线用药。
Pediatrics. 2021 Mar;147(3). doi: 10.1542/peds.2020-017830.
4
Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure.宫内阿片类药物暴露所致新生儿戒断综合征的当前管理
J Pediatr. 2014 Sep;165(3):440-6. doi: 10.1016/j.jpeds.2014.05.010. Epub 2014 Jun 16.